Wegovy

Latest four-week snapshot through 2026-08-05 · 1 wave. Use the controls above to change the window.

GLP-1 Medications · 1 wave · n=72 answers, pooled

By assistant

How often each assistant brings the brand up in recommendation answers.

Share of recommendations over time

Wave-by-wave share of recommendation answers that named this brand.

What they call it

Recurring descriptions in the assistants' own words, grouped by theme.

• fda-approved for weight management ×29

  “FDA-Approved for Weight Loss”

• weekly dosing ×27

  “Weekly Injections”

• fda-approved ×20

  “* **Ozempic** is specifically FDA-approved to lower blood sugar in adults with type 2 diabetes and to reduce the risk of major cardiovascular events (like stroke or heart attack) in diabetics with established heart disease.”

• semaglutide ×16

  “* **How it compares:** Head-to-head data and clinical comparisons show that Zepbound generally leads to greater weight loss than Wegovy (semaglutide), where average weight loss typically hovers around 15%.”

• cardiovascular protection ×13

  “* **Cardiovascular Protection:** Wegovy is FDA-approved to **reduce the risk of major cardiovascular events**—including heart attacks, strokes, and cardiovascular death—in adults with established heart disease and obesity.”

• greater weight loss ×13

  “Because of this higher dose, clinical trials show patients on Wegovy achieve greater average weight loss (about 15% to 18% of their body weight) compared to those on Ozempic (about 8% to 14%).”

• once-weekly injection ×12

  “It is available as a **once-weekly injection** or as a **once-daily oral pill** (which is formulated at a high 25 mg dose specifically for weight loss).”

• 15% to 21% average weight loss ×10

  “If you must pick exactly one, you should choose **Wegovy**.”

• significant weight loss ×10

  “* **Substantial Weight Loss:**”

• weight loss ×10

  “If your primary goal is weight loss, Wegovy is the superior clinical choice.”

In their words

262 exact quoted mentions in this snapshot, grouped by coded tone.

What they recommend

“**Wegovy** – specifically approved for chronic weight management”

“**Wegovy (semaglutide)** – The other major option, now available in multiple forms. It shows about 14.9% average weight loss with the injection and 13.6% with the 25 mg tablet in pivotal trials, plus it's the only FDA-approved option with a”

“These undergo formal FDA review for safety and efficacy, so their approved labeling and core efficacy claims are backed by clinical trial data.”

“FDA-approved manufacturers (Novo Nordisk's Ozempic/Wegovy, Eli Lilly's Mounjaro/Zepbound)”

“CMS is providing eligible Medicare beneficiaries access to certain GLP-1 medications for $50 per month beginning July 1, 2026, through December 31, 2027, as part of a demonstration program. This covers injectable Mounjaro, Ozempic, and Zepb”

Where they hedge

“**Wegovy** – FDA-approved specifically for chronic weight management”

“**Wegovy** (semaglutide) – weekly injection”

“**Semaglutide** – sold as Ozempic (diabetes) and Wegovy (weight loss); also an oral version, Rybelsus”

“**Semaglutide** – sold as **Wegovy** (approved for weight loss)”

“Wegovy is approved for weight management dosed up to 2.4 mg weekly”

What they warn about

“Novo Nordisk (maker of Ozempic and Wegovy) has been hit with **multiple FDA warning letters in 2026** for misleading TV ads.”

“The FDA approved a 7.2 mg dose of Wegovy in March 2026, a dose that wasn't included in the trial Lilly's ads cite.”

“**Do not combine Zepbound with another GLP-1** (such as Wegovy, Ozempic, or Foundayo) unless a clinician explicitly directs a transition plan.”

“**Wegovy** and **Zepbound** may be more effective for many people and are weekly rather than daily injections, but without coverage they are often still expensive.”

“Head-to-head data and real-world studies show that tirzepatide is significantly more effective for weight loss than semaglutide (the active ingredient in Ozempic and Wegovy), which typically results in about 15% weight loss.”

The substitution map

Which competitors assistants suggest when shoppers ask for something cheaper.

Where this comes from

52 of 262 mentions appear alongside an identifiable web citation. Citation does not establish causation.

Where they send you

Stores and sites assistants name as places to buy this brand.

Method: fixed shopper questions asked repeatedly to Claude, OpenAI GPT and Gemini with web search on. Shares are the percentage of recommendation answers mentioning the brand. Quotes are AI outputs; full transcripts are kept as receipts.